#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=http://www.who.int/csr/disease/swineflu/guidance/national_authorities/en/index.html
1-1	0-83	http://www.who.int/csr/disease/swineflu/guidance/national_authorities/en/index.html	place	new	_	_

#Text=( ( MM ) ) What does the WHO recommend for those individuals affected by H1N1 ? How does H1N1 affect someone who is infected ?
2-1	84-85	(	_	_	_	_
2-2	86-87	(	_	_	_	_
2-3	88-90	MM	person	new	coref	15-3
2-4	91-92	)	_	_	_	_
2-5	93-94	)	_	_	_	_
2-6	95-99	What	_	_	_	_
2-7	100-104	does	_	_	_	_
2-8	105-108	the	_	_	_	_
2-9	109-112	WHO	_	_	_	_
2-10	113-122	recommend	_	_	_	_
2-11	123-126	for	_	_	_	_
2-12	127-132	those	person[3]	new[3]	_	_
2-13	133-144	individuals	person[3]	new[3]	_	_
2-14	145-153	affected	_	_	_	_
2-15	154-156	by	_	_	_	_
2-16	157-161	H1N1	abstract	new	coref	2-20
2-17	162-163	?	_	_	_	_
2-18	164-167	How	_	_	_	_
2-19	168-172	does	_	_	_	_
2-20	173-177	H1N1	abstract	giv	coref	3-8
2-21	178-184	affect	_	_	_	_
2-22	185-192	someone	person	new	ana	12-22[92_0]
2-23	193-196	who	_	_	_	_
2-24	197-199	is	_	_	_	_
2-25	200-208	infected	_	_	_	_
2-26	209-210	?	_	_	_	_

#Text=( ( KM ) ) Since the H1N1 pandemic virus is now the dominant influenza virus circulating worldwide , most cases of influenza-like illness are likely pandemic influenza .
3-1	211-212	(	_	_	_	_
3-2	213-214	(	_	_	_	_
3-3	215-217	KM	quantity	new	coref	16-3
3-4	218-219	)	_	_	_	_
3-5	220-221	)	_	_	_	_
3-6	222-227	Since	_	_	_	_
3-7	228-231	the	abstract[10]	new[10]	coref	3-12[12_10]
3-8	232-236	H1N1	object|abstract[10]	giv|new[10]	coref	6-3
3-9	237-245	pandemic	plant|abstract[10]	new|new[10]	coref	3-27
3-10	246-251	virus	abstract[10]	new[10]	_	_
3-11	252-254	is	_	_	_	_
3-12	255-258	now	abstract[12]	giv[12]	coref	6-1[42_12]
3-13	259-262	the	abstract[12]	giv[12]	_	_
3-14	263-271	dominant	abstract[12]	giv[12]	_	_
3-15	272-281	influenza	abstract|abstract[12]	new|giv[12]	coref	3-27[17_0]
3-16	282-287	virus	abstract[12]	giv[12]	_	_
3-17	288-299	circulating	_	_	_	_
3-18	300-309	worldwide	place	new	coref	6-8
3-19	310-311	,	_	_	_	_
3-20	312-316	most	abstract[14]	new[14]	_	_
3-21	317-322	cases	abstract[14]	new[14]	_	_
3-22	323-325	of	abstract[14]	new[14]	_	_
3-23	326-340	influenza-like	abstract[14]|abstract[15]	new[14]|new[15]	coref	5-10[30_15]
3-24	341-348	illness	abstract[14]|abstract[15]	new[14]|new[15]	_	_
3-25	349-352	are	_	_	_	_
3-26	353-359	likely	_	_	_	_
3-27	360-368	pandemic	animal|abstract[17]	giv|giv[17]	coref|coref	5-31|5-31[39_17]
3-28	369-378	influenza	abstract[17]	giv[17]	_	_
3-29	379-380	.	_	_	_	_

#Text=Typical symptoms to watch for include fever , cough , headache , body aches , sore throat and runny nose .
4-1	381-388	Typical	abstract[18]	new[18]	coref	5-14[32_18]
4-2	389-397	symptoms	abstract[18]	new[18]	_	_
4-3	398-400	to	_	_	_	_
4-4	401-406	watch	_	_	_	_
4-5	407-410	for	_	_	_	_
4-6	411-418	include	_	_	_	_
4-7	419-424	fever	abstract	new	coref	14-7[109_0]
4-8	425-426	,	_	_	_	_
4-9	427-432	cough	abstract	new	coref	18-14
4-10	433-434	,	_	_	_	_
4-11	435-443	headache	abstract	new	coref	18-16
4-12	444-445	,	_	_	_	_
4-13	446-450	body	object|abstract[23]	new|new[23]	_	_
4-14	451-456	aches	abstract[23]	new[23]	_	_
4-15	457-458	,	_	_	_	_
4-16	459-463	sore	abstract[24]	new[24]	coref	18-23[138_24]
4-17	464-470	throat	abstract[24]	new[24]	_	_
4-18	471-474	and	_	_	_	_
4-19	475-480	runny	object[25]	new[25]	coref	18-26[139_25]
4-20	481-485	nose	object[25]	new[25]	_	_
4-21	486-487	.	_	_	_	_

#Text=WHO advises health care providers to treat people with influenza-like illness based on their symptoms and the progress of their illness , and not to wait for laboratory confirmation of pandemic influenza .
5-1	488-491	WHO	_	_	_	_
5-2	492-499	advises	_	_	_	_
5-3	500-506	health	abstract|person[28]	new|new[28]	coref	7-8
5-4	507-511	care	abstract|person[28]	new|new[28]	coref	20-6[147_0]
5-5	512-521	providers	person[28]	new[28]	_	_
5-6	522-524	to	_	_	_	_
5-7	525-530	treat	_	_	_	_
5-8	531-537	people	person	new	ana	5-14
5-9	538-542	with	_	_	_	_
5-10	543-557	influenza-like	abstract[30]	giv[30]	coref	5-20[35_30]
5-11	558-565	illness	abstract[30]	giv[30]	_	_
5-12	566-571	based	_	_	_	_
5-13	572-574	on	_	_	_	_
5-14	575-580	their	person|abstract[32]	giv|giv[32]	ana|coref	5-20|11-4[75_32]
5-15	581-589	symptoms	abstract[32]	giv[32]	_	_
5-16	590-593	and	abstract[32]	giv[32]	_	_
5-17	594-597	the	abstract[32]|abstract[33]	giv[32]|new[33]	_	_
5-18	598-606	progress	abstract[32]|abstract[33]	giv[32]|new[33]	_	_
5-19	607-609	of	abstract[32]|abstract[33]	giv[32]|new[33]	_	_
5-20	610-615	their	abstract[32]|abstract[33]|person|abstract[35]	giv[32]|new[33]|giv|giv[35]	coref|coref	7-23[52_35]|13-1[101_0]
5-21	616-623	illness	abstract[32]|abstract[33]|abstract[35]	giv[32]|new[33]|giv[35]	_	_
5-22	624-625	,	_	_	_	_
5-23	626-629	and	_	_	_	_
5-24	630-633	not	_	_	_	_
5-25	634-636	to	_	_	_	_
5-26	637-641	wait	_	_	_	_
5-27	642-645	for	_	_	_	_
5-28	646-656	laboratory	place|abstract[37]	new|new[37]	coref	11-36
5-29	657-669	confirmation	abstract[37]	new[37]	_	_
5-30	670-672	of	abstract[37]	new[37]	_	_
5-31	673-681	pandemic	abstract[37]|animal|abstract[39]	new[37]|giv|giv[39]	coref|coref	6-2|9-12[0_39]
5-32	682-691	influenza	abstract[37]|abstract[39]	new[37]|giv[39]	_	_
5-33	692-693	.	_	_	_	_

#Text=The pandemic H1N1 virus has already spread worldwide .
6-1	694-697	The	abstract[42]	giv[42]	coref	7-30[54_42]
6-2	698-706	pandemic	plant|abstract[42]	giv|giv[42]	coref	9-11
6-3	707-711	H1N1	object|abstract[42]	giv|giv[42]	coref	8-24
6-4	712-717	virus	abstract[42]	giv[42]	_	_
6-5	718-721	has	_	_	_	_
6-6	722-729	already	_	_	_	_
6-7	730-736	spread	_	_	_	_
6-8	737-746	worldwide	place	giv	_	_
6-9	747-748	.	_	_	_	_

#Text=Regarding laboratory testing of cases , public health authorities and WHO partners continue to do selective testing of samples from patients with influenza-like illness to characterize outbreaks , monitor the virus and identify disease trends .
7-1	749-758	Regarding	_	_	_	_
7-2	759-769	laboratory	abstract[44]	new[44]	_	_
7-3	770-777	testing	abstract[44]	new[44]	_	_
7-4	778-780	of	abstract[44]	new[44]	_	_
7-5	781-786	cases	abstract[44]|abstract	new[44]|new	_	_
7-6	787-788	,	abstract[44]	new[44]	_	_
7-7	789-795	public	abstract[44]|organization[47]	new[44]|new[47]	_	_
7-8	796-802	health	abstract[44]|abstract|organization[47]	new[44]|giv|new[47]	_	_
7-9	803-814	authorities	abstract[44]|organization[47]	new[44]|new[47]	_	_
7-10	815-818	and	_	_	_	_
7-11	819-822	WHO	_	_	_	_
7-12	823-831	partners	person	new	_	_
7-13	832-840	continue	_	_	_	_
7-14	841-843	to	_	_	_	_
7-15	844-846	do	_	_	_	_
7-16	847-856	selective	abstract[49]	new[49]	_	_
7-17	857-864	testing	abstract[49]	new[49]	_	_
7-18	865-867	of	abstract[49]	new[49]	_	_
7-19	868-875	samples	abstract[49]|object	new[49]|new	_	_
7-20	876-880	from	abstract[49]	new[49]	_	_
7-21	881-889	patients	abstract[49]|person[51]	new[49]|new[51]	coref	11-2[74_51]
7-22	890-894	with	abstract[49]|person[51]	new[49]|new[51]	_	_
7-23	895-909	influenza-like	abstract[49]|person[51]|abstract[52]	new[49]|new[51]|giv[52]	coref	11-6[76_52]
7-24	910-917	illness	abstract[49]|person[51]|abstract[52]	new[49]|new[51]|giv[52]	_	_
7-25	918-920	to	_	_	_	_
7-26	921-933	characterize	_	_	_	_
7-27	934-943	outbreaks	event	new	_	_
7-28	944-945	,	_	_	_	_
7-29	946-953	monitor	_	_	_	_
7-30	954-957	the	abstract[54]	giv[54]	coref	10-15[0_54]
7-31	958-963	virus	abstract[54]	giv[54]	_	_
7-32	964-967	and	_	_	_	_
7-33	968-976	identify	_	_	_	_
7-34	977-984	disease	abstract|abstract[56]	new|new[56]	coref	12-7[87_0]
7-35	985-991	trends	abstract[56]	new[56]	_	_
7-36	992-993	.	_	_	_	_

#Text=Anti-viral drugs ( which are medicines that act directly on viruses to stop them from multiplying ) should not be taken to prevent H1N1 .
8-1	994-1004	Anti-viral	substance[57]	new[57]	coref	9-3[63_57]
8-2	1005-1010	drugs	substance[57]	new[57]	_	_
8-3	1011-1012	(	_	_	_	_
8-4	1013-1018	which	_	_	_	_
8-5	1019-1022	are	_	_	_	_
8-6	1023-1032	medicines	substance	new	_	_
8-7	1033-1037	that	_	_	_	_
8-8	1038-1041	act	_	_	_	_
8-9	1042-1050	directly	_	_	_	_
8-10	1051-1053	on	_	_	_	_
8-11	1054-1061	viruses	substance	new	ana	8-14
8-12	1062-1064	to	_	_	_	_
8-13	1065-1069	stop	_	_	_	_
8-14	1070-1074	them	substance	giv	coref	16-20[121_0]
8-15	1075-1079	from	_	_	_	_
8-16	1080-1091	multiplying	abstract	new	_	_
8-17	1092-1093	)	_	_	_	_
8-18	1094-1100	should	_	_	_	_
8-19	1101-1104	not	_	_	_	_
8-20	1105-1107	be	_	_	_	_
8-21	1108-1113	taken	_	_	_	_
8-22	1114-1116	to	_	_	_	_
8-23	1117-1124	prevent	_	_	_	_
8-24	1125-1129	H1N1	abstract	giv	coref	15-8
8-25	1130-1131	.	_	_	_	_

#Text=There are two antiviral drugs are being used to treat pandemic influenza infections .
9-1	1132-1137	There	_	_	_	_
9-2	1138-1141	are	_	_	_	_
9-3	1142-1145	two	substance[63]	giv[63]	_	_
9-4	1146-1155	antiviral	substance[63]	giv[63]	_	_
9-5	1156-1161	drugs	substance[63]	giv[63]	_	_
9-6	1162-1165	are	_	_	_	_
9-7	1166-1171	being	_	_	_	_
9-8	1172-1176	used	_	_	_	_
9-9	1177-1179	to	_	_	_	_
9-10	1180-1185	treat	_	_	_	_
9-11	1186-1194	pandemic	object|abstract[66]	giv|new[66]	ana|coref	10-1[0_66]|11-13
9-12	1195-1204	influenza	abstract|abstract[66]	giv|new[66]	coref	11-13[78_0]
9-13	1205-1215	infections	abstract[66]	new[66]	_	_
9-14	1216-1217	.	_	_	_	_

#Text=These are oseltamivir and zanamivir , which both block the action of an influenza virus protein called neuraminidase .
10-1	1218-1223	These	abstract	giv	coref	10-3[68_0]
10-2	1224-1227	are	_	_	_	_
10-3	1228-1239	oseltamivir	abstract[68]	giv[68]	coref	11-21[0_68]
10-4	1240-1243	and	abstract[68]	giv[68]	_	_
10-5	1244-1253	zanamivir	abstract[68]|object	giv[68]|new	coref	12-36
10-6	1254-1255	,	_	_	_	_
10-7	1256-1261	which	_	_	_	_
10-8	1262-1266	both	_	_	_	_
10-9	1267-1272	block	_	_	_	_
10-10	1273-1276	the	abstract[70]	new[70]	_	_
10-11	1277-1283	action	abstract[70]	new[70]	_	_
10-12	1284-1286	of	abstract[70]	new[70]	_	_
10-13	1287-1289	an	abstract[70]|substance[72]	new[70]|new[72]	_	_
10-14	1290-1299	influenza	abstract[70]|substance[72]	new[70]|new[72]	_	_
10-15	1300-1305	virus	abstract[70]|abstract|substance[72]	new[70]|giv|new[72]	_	_
10-16	1306-1313	protein	abstract[70]|substance[72]	new[70]|new[72]	_	_
10-17	1314-1320	called	_	_	_	_
10-18	1321-1334	neuraminidase	abstract	new	_	_
10-19	1335-1336	.	_	_	_	_

#Text=For patients with symptoms of severe illness that are probably due to pandemic influenza , WHO recommends that treatment with oseltamivir should start immediately , no matter when the illness started and without waiting for laboratory results to confirm infection .
11-1	1337-1340	For	_	_	_	_
11-2	1341-1349	patients	person[74]	giv[74]	coref	12-2[85_74]
11-3	1350-1354	with	person[74]	giv[74]	_	_
11-4	1355-1363	symptoms	person[74]|abstract[75]	giv[74]|giv[75]	coref	12-45[0_75]
11-5	1364-1366	of	person[74]|abstract[75]	giv[74]|giv[75]	_	_
11-6	1367-1373	severe	person[74]|abstract[75]|abstract[76]	giv[74]|giv[75]|giv[76]	coref	11-29[81_76]
11-7	1374-1381	illness	person[74]|abstract[75]|abstract[76]	giv[74]|giv[75]|giv[76]	_	_
11-8	1382-1386	that	_	_	_	_
11-9	1387-1390	are	_	_	_	_
11-10	1391-1399	probably	_	_	_	_
11-11	1400-1403	due	_	_	_	_
11-12	1404-1406	to	_	_	_	_
11-13	1407-1415	pandemic	animal|abstract[78]	giv|giv[78]	coref|coref	12-10|12-10[89_78]
11-14	1416-1425	influenza	abstract[78]	giv[78]	_	_
11-15	1426-1427	,	_	_	_	_
11-16	1428-1431	WHO	_	_	_	_
11-17	1432-1442	recommends	_	_	_	_
11-18	1443-1447	that	_	_	_	_
11-19	1448-1457	treatment	abstract[79]	new[79]	coref	12-31[94_79]
11-20	1458-1462	with	abstract[79]	new[79]	_	_
11-21	1463-1474	oseltamivir	abstract[79]|substance	new[79]|giv	coref	12-33[95_0]
11-22	1475-1481	should	_	_	_	_
11-23	1482-1487	start	_	_	_	_
11-24	1488-1499	immediately	_	_	_	_
11-25	1500-1501	,	_	_	_	_
11-26	1502-1504	no	_	_	_	_
11-27	1505-1511	matter	_	_	_	_
11-28	1512-1516	when	_	_	_	_
11-29	1517-1520	the	abstract[81]	giv[81]	coref	19-9[144_81]
11-30	1521-1528	illness	abstract[81]	giv[81]	_	_
11-31	1529-1536	started	_	_	_	_
11-32	1537-1540	and	_	_	_	_
11-33	1541-1548	without	_	_	_	_
11-34	1549-1556	waiting	_	_	_	_
11-35	1557-1560	for	_	_	_	_
11-36	1561-1571	laboratory	place|abstract[83]	giv|new[83]	coref	12-51[99_83]
11-37	1572-1579	results	abstract[83]	new[83]	_	_
11-38	1580-1582	to	_	_	_	_
11-39	1583-1590	confirm	_	_	_	_
11-40	1591-1600	infection	event	new	_	_
11-41	1601-1602	.	_	_	_	_

#Text=For patients at higher risk for serious disease from pandemic influenza , including pregnant women , children under age 5 and those with certain underlying medical conditions , WHO recommends treatment with either oseltamivir or zanamivir as soon as possible after the onset of symptoms , and without waiting for the results of laboratory tests .
12-1	1603-1606	For	_	_	_	_
12-2	1607-1615	patients	person[85]	giv[85]	_	_
12-3	1616-1618	at	person[85]	giv[85]	_	_
12-4	1619-1625	higher	person[85]|abstract[86]	giv[85]|new[86]	coref	13-10[0_86]
12-5	1626-1630	risk	person[85]|abstract[86]	giv[85]|new[86]	_	_
12-6	1631-1634	for	person[85]|abstract[86]	giv[85]|new[86]	_	_
12-7	1635-1642	serious	person[85]|abstract[86]|abstract[87]	giv[85]|new[86]|giv[87]	_	_
12-8	1643-1650	disease	person[85]|abstract[86]|abstract[87]	giv[85]|new[86]|giv[87]	_	_
12-9	1651-1655	from	person[85]|abstract[86]|abstract[87]	giv[85]|new[86]|giv[87]	_	_
12-10	1656-1664	pandemic	person[85]|abstract[86]|abstract[87]|animal|abstract[89]	giv[85]|new[86]|giv[87]|giv|giv[89]	coref|coref	16-21[0_89]|18-4
12-11	1665-1674	influenza	person[85]|abstract[86]|abstract[87]|abstract[89]	giv[85]|new[86]|giv[87]|giv[89]	_	_
12-12	1675-1676	,	person[85]	giv[85]	_	_
12-13	1677-1686	including	person[85]	giv[85]	_	_
12-14	1687-1695	pregnant	person[85]	giv[85]	_	_
12-15	1696-1701	women	person[85]	giv[85]	_	_
12-16	1702-1703	,	person[85]	giv[85]	_	_
12-17	1704-1712	children	person[85]|person[90]	giv[85]|new[90]	_	_
12-18	1713-1718	under	person[85]|person[90]	giv[85]|new[90]	_	_
12-19	1719-1722	age	person[85]|person[90]|abstract[91]	giv[85]|new[90]|new[91]	_	_
12-20	1723-1724	5	person[85]|person[90]|abstract[91]	giv[85]|new[90]|new[91]	_	_
12-21	1725-1728	and	person[85]	giv[85]	_	_
12-22	1729-1734	those	person[85]|person[92]	giv[85]|giv[92]	coref	15-10[0_92]
12-23	1735-1739	with	person[85]|person[92]	giv[85]|giv[92]	_	_
12-24	1740-1747	certain	person[85]|person[92]|abstract[93]	giv[85]|giv[92]|new[93]	_	_
12-25	1748-1758	underlying	person[85]|person[92]|abstract[93]	giv[85]|giv[92]|new[93]	_	_
12-26	1759-1766	medical	person[85]|person[92]|abstract[93]	giv[85]|giv[92]|new[93]	_	_
12-27	1767-1777	conditions	person[85]|person[92]|abstract[93]	giv[85]|giv[92]|new[93]	_	_
12-28	1778-1779	,	_	_	_	_
12-29	1780-1783	WHO	_	_	_	_
12-30	1784-1794	recommends	_	_	_	_
12-31	1795-1804	treatment	abstract[94]	giv[94]	coref	19-15[0_94]
12-32	1805-1809	with	abstract[94]	giv[94]	_	_
12-33	1810-1816	either	abstract[94]|substance[95]	giv[94]|giv[95]	_	_
12-34	1817-1828	oseltamivir	abstract[94]|substance[95]	giv[94]|giv[95]	_	_
12-35	1829-1831	or	abstract[94]	giv[94]	_	_
12-36	1832-1841	zanamivir	abstract[94]|substance	giv[94]|giv	_	_
12-37	1842-1844	as	abstract[94]	giv[94]	_	_
12-38	1845-1849	soon	abstract[94]	giv[94]	_	_
12-39	1850-1852	as	abstract[94]	giv[94]	_	_
12-40	1853-1861	possible	abstract[94]	giv[94]	_	_
12-41	1862-1867	after	_	_	_	_
12-42	1868-1871	the	event[97]	new[97]	_	_
12-43	1872-1877	onset	event[97]	new[97]	_	_
12-44	1878-1880	of	event[97]	new[97]	_	_
12-45	1881-1889	symptoms	event[97]|abstract	new[97]|giv	coref	13-15[104_0]
12-46	1890-1891	,	_	_	_	_
12-47	1892-1895	and	_	_	_	_
12-48	1896-1903	without	_	_	_	_
12-49	1904-1911	waiting	_	_	_	_
12-50	1912-1915	for	_	_	_	_
12-51	1916-1919	the	abstract[99]	giv[99]	_	_
12-52	1920-1927	results	abstract[99]	giv[99]	_	_
12-53	1928-1930	of	abstract[99]	giv[99]	_	_
12-54	1931-1941	laboratory	abstract[99]|abstract[100]	giv[99]|new[100]	_	_
12-55	1942-1947	tests	abstract[99]|abstract[100]	giv[99]|new[100]	_	_
12-56	1948-1949	.	_	_	_	_

#Text=Otherwise healthy people who are not from a higher risk group but who have persistent or rapidly worsening symptoms should be treated with antivirals .
13-1	1950-1959	Otherwise	person[101]	giv[101]	coref	17-16[123_101]
13-2	1960-1967	healthy	person[101]	giv[101]	_	_
13-3	1968-1974	people	person[101]	giv[101]	_	_
13-4	1975-1978	who	_	_	_	_
13-5	1979-1982	are	_	_	_	_
13-6	1983-1986	not	_	_	_	_
13-7	1987-1991	from	_	_	_	_
13-8	1992-1993	a	person[103]	new[103]	_	_
13-9	1994-2000	higher	person[103]	new[103]	_	_
13-10	2001-2005	risk	abstract|person[103]	giv|new[103]	_	_
13-11	2006-2011	group	person[103]	new[103]	_	_
13-12	2012-2015	but	_	_	_	_
13-13	2016-2019	who	_	_	_	_
13-14	2020-2024	have	_	_	_	_
13-15	2025-2035	persistent	abstract[104]	giv[104]	coref	14-1[106_104]
13-16	2036-2038	or	abstract[104]	giv[104]	_	_
13-17	2039-2046	rapidly	abstract[104]	giv[104]	_	_
13-18	2047-2056	worsening	abstract[104]	giv[104]	_	_
13-19	2057-2065	symptoms	abstract[104]	giv[104]	_	_
13-20	2066-2072	should	_	_	_	_
13-21	2073-2075	be	_	_	_	_
13-22	2076-2083	treated	_	_	_	_
13-23	2084-2088	with	_	_	_	_
13-24	2089-2099	antivirals	substance	new	_	_
13-25	2100-2101	.	_	_	_	_

#Text=These symptoms include difficulty breathing or a high fever that lasts beyond three days .
14-1	2102-2107	These	abstract[106]	giv[106]	_	_
14-2	2108-2116	symptoms	abstract[106]	giv[106]	_	_
14-3	2117-2124	include	_	_	_	_
14-4	2125-2135	difficulty	abstract|abstract[108]	new|new[108]	coref|coref	20-15|20-15[152_108]
14-5	2136-2145	breathing	abstract[108]	new[108]	_	_
14-6	2146-2148	or	_	_	_	_
14-7	2149-2150	a	abstract[109]	giv[109]	coref	18-12[0_109]
14-8	2151-2155	high	abstract[109]	giv[109]	_	_
14-9	2156-2161	fever	abstract[109]	giv[109]	_	_
14-10	2162-2166	that	_	_	_	_
14-11	2167-2172	lasts	_	_	_	_
14-12	2173-2179	beyond	_	_	_	_
14-13	2180-2185	three	time[110]	new[110]	coref	20-29[156_110]
14-14	2186-2190	days	time[110]	new[110]	_	_
14-15	2191-2192	.	_	_	_	_

#Text=( ( MM ) ) How does H1N1 affect someone who is infected ?
15-1	2193-2194	(	_	_	_	_
15-2	2195-2196	(	_	_	_	_
15-3	2197-2199	MM	person	giv	_	_
15-4	2200-2201	)	_	_	_	_
15-5	2202-2203	)	_	_	_	_
15-6	2204-2207	How	_	_	_	_
15-7	2208-2212	does	_	_	_	_
15-8	2213-2217	H1N1	abstract	giv	coref	16-7
15-9	2218-2224	affect	_	_	_	_
15-10	2225-2232	someone	person	giv	_	_
15-11	2233-2236	who	_	_	_	_
15-12	2237-2239	is	_	_	_	_
15-13	2240-2248	infected	_	_	_	_
15-14	2249-2250	?	_	_	_	_

#Text=( ( KM ) ) Pandemic H1N1 virus is spread from person to person in the same way that seasonal influenza viruses are spread .
16-1	2251-2252	(	_	_	_	_
16-2	2253-2254	(	person[115]	new[115]	_	_
16-3	2255-2257	KM	quantity|person[115]	giv|new[115]	_	_
16-4	2258-2259	)	person[115]	new[115]	_	_
16-5	2260-2261	)	person[115]	new[115]	_	_
16-6	2262-2270	Pandemic	person[115]	new[115]	_	_
16-7	2271-2275	H1N1	person[115]|object	new[115]|giv	_	_
16-8	2276-2281	virus	person[115]	new[115]	_	_
16-9	2282-2284	is	_	_	_	_
16-10	2285-2291	spread	_	_	_	_
16-11	2292-2296	from	_	_	_	_
16-12	2297-2303	person	person	new	_	_
16-13	2304-2306	to	_	_	_	_
16-14	2307-2313	person	person	new	_	_
16-15	2314-2316	in	_	_	_	_
16-16	2317-2320	the	abstract[119]	new[119]	ana	17-1[0_119]
16-17	2321-2325	same	abstract[119]	new[119]	_	_
16-18	2326-2329	way	abstract[119]	new[119]	_	_
16-19	2330-2334	that	abstract[119]	new[119]	_	_
16-20	2335-2343	seasonal	abstract[119]|substance[121]	new[119]|giv[121]	_	_
16-21	2344-2353	influenza	abstract[119]|abstract|substance[121]	new[119]|giv|giv[121]	coref	18-3[130_0]
16-22	2354-2361	viruses	abstract[119]|substance[121]	new[119]|giv[121]	_	_
16-23	2362-2365	are	abstract[119]	new[119]	_	_
16-24	2366-2372	spread	abstract[119]	new[119]	_	_
16-25	2373-2374	.	_	_	_	_

#Text=It is transmitted as easily as the normal seasonal flu and can be passed to other people by exposure to infected droplets expelled by coughing or sneezing that can be inhaled , or that can contaminate hands or surfaces .
17-1	2375-2377	It	abstract	giv	_	_
17-2	2378-2380	is	_	_	_	_
17-3	2381-2392	transmitted	_	_	_	_
17-4	2393-2395	as	_	_	_	_
17-5	2396-2402	easily	_	_	_	_
17-6	2403-2405	as	_	_	_	_
17-7	2406-2409	the	_	_	_	_
17-8	2410-2416	normal	_	_	_	_
17-9	2417-2425	seasonal	_	_	_	_
17-10	2426-2429	flu	_	_	_	_
17-11	2430-2433	and	_	_	_	_
17-12	2434-2437	can	_	_	_	_
17-13	2438-2440	be	_	_	_	_
17-14	2441-2447	passed	_	_	_	_
17-15	2448-2450	to	_	_	_	_
17-16	2451-2456	other	person[123]	giv[123]	coref	19-1[141_123]
17-17	2457-2463	people	person[123]	giv[123]	_	_
17-18	2464-2466	by	_	_	_	_
17-19	2467-2475	exposure	abstract[124]	new[124]	_	_
17-20	2476-2478	to	abstract[124]	new[124]	_	_
17-21	2479-2487	infected	abstract[124]|object[125]	new[124]|new[125]	_	_
17-22	2488-2496	droplets	abstract[124]|object[125]	new[124]|new[125]	_	_
17-23	2497-2505	expelled	_	_	_	_
17-24	2506-2508	by	_	_	_	_
17-25	2509-2517	coughing	_	_	_	_
17-26	2518-2520	or	_	_	_	_
17-27	2521-2529	sneezing	_	_	_	_
17-28	2530-2534	that	_	_	_	_
17-29	2535-2538	can	_	_	_	_
17-30	2539-2541	be	_	_	_	_
17-31	2542-2549	inhaled	_	_	_	_
17-32	2550-2551	,	_	_	_	_
17-33	2552-2554	or	_	_	_	_
17-34	2555-2559	that	_	_	_	_
17-35	2560-2563	can	_	_	_	_
17-36	2564-2575	contaminate	_	_	_	_
17-37	2576-2581	hands	object	new	_	_
17-38	2582-2584	or	_	_	_	_
17-39	2585-2593	surfaces	place	new	_	_
17-40	2594-2595	.	_	_	_	_

#Text=Signs of the pandemic influenza are flu-like , including malaise , fever , cough , headache , muscle and joint pain , sore throat and runny nose , and sometimes vomiting and diarrhoea .
18-1	2596-2601	Signs	abstract[128]	new[128]	coref	18-7[131_128]
18-2	2602-2604	of	abstract[128]	new[128]	_	_
18-3	2605-2608	the	abstract[128]|abstract[130]	new[128]|giv[130]	coref	19-6[143_130]
18-4	2609-2617	pandemic	abstract[128]|animal|abstract[130]	new[128]|giv|giv[130]	coref	19-6
18-5	2618-2627	influenza	abstract[128]|abstract[130]	new[128]|giv[130]	_	_
18-6	2628-2631	are	_	_	_	_
18-7	2632-2640	flu-like	abstract[131]	giv[131]	_	_
18-8	2641-2642	,	abstract[131]	giv[131]	_	_
18-9	2643-2652	including	abstract[131]	giv[131]	_	_
18-10	2653-2660	malaise	abstract[131]|abstract	giv[131]|new	_	_
18-11	2661-2662	,	abstract[131]	giv[131]	_	_
18-12	2663-2668	fever	abstract[131]|abstract	giv[131]|giv	coref	20-20[153_0]
18-13	2669-2670	,	abstract[131]	giv[131]	_	_
18-14	2671-2676	cough	abstract[131]|abstract	giv[131]|giv	_	_
18-15	2677-2678	,	abstract[131]	giv[131]	_	_
18-16	2679-2687	headache	abstract[131]|abstract	giv[131]|giv	_	_
18-17	2688-2689	,	abstract[131]	giv[131]	_	_
18-18	2690-2696	muscle	abstract[131]|object	giv[131]|new	_	_
18-19	2697-2700	and	abstract[131]	giv[131]	_	_
18-20	2701-2706	joint	abstract[131]|abstract[137]	giv[131]|new[137]	_	_
18-21	2707-2711	pain	abstract[131]|abstract[137]	giv[131]|new[137]	_	_
18-22	2712-2713	,	abstract[131]	giv[131]	_	_
18-23	2714-2718	sore	abstract[131]|abstract[138]	giv[131]|giv[138]	_	_
18-24	2719-2725	throat	abstract[131]|abstract[138]	giv[131]|giv[138]	_	_
18-25	2726-2729	and	abstract[131]	giv[131]	_	_
18-26	2730-2735	runny	abstract[131]|object[139]	giv[131]|giv[139]	_	_
18-27	2736-2740	nose	abstract[131]|object[139]	giv[131]|giv[139]	_	_
18-28	2741-2742	,	_	_	_	_
18-29	2743-2746	and	_	_	_	_
18-30	2747-2756	sometimes	_	_	_	_
18-31	2757-2765	vomiting	_	_	_	_
18-32	2766-2769	and	_	_	_	_
18-33	2770-2779	diarrhoea	abstract	new	_	_
18-34	2780-2781	.	_	_	_	_

#Text=The majority of people with pandemic influenza experience mild illness and recover fully without treatment .
19-1	2782-2785	The	person[141]	giv[141]	coref	20-3[0_141]
19-2	2786-2794	majority	person[141]	giv[141]	_	_
19-3	2795-2797	of	person[141]	giv[141]	_	_
19-4	2798-2804	people	person[141]	giv[141]	_	_
19-5	2805-2809	with	person[141]	giv[141]	_	_
19-6	2810-2818	pandemic	person[141]|animal|abstract[143]	giv[141]|giv|giv[143]	_	_
19-7	2819-2828	influenza	person[141]|abstract[143]	giv[141]|giv[143]	_	_
19-8	2829-2839	experience	_	_	_	_
19-9	2840-2844	mild	abstract[144]	giv[144]	_	_
19-10	2845-2852	illness	abstract[144]	giv[144]	_	_
19-11	2853-2856	and	_	_	_	_
19-12	2857-2864	recover	_	_	_	_
19-13	2865-2870	fully	_	_	_	_
19-14	2871-2878	without	_	_	_	_
19-15	2879-2888	treatment	abstract	giv	_	_
19-16	2889-2890	.	_	_	_	_

#Text=However , people should seek medical care if they experience shortness of breath or difficulty breathing , or if a fever , and especially high fever , continues more than three days .
20-1	2891-2898	However	_	_	_	_
20-2	2899-2900	,	_	_	_	_
20-3	2901-2907	people	person	giv	ana	20-9
20-4	2908-2914	should	_	_	_	_
20-5	2915-2919	seek	_	_	_	_
20-6	2920-2927	medical	abstract[147]	giv[147]	coref	21-12[159_147]
20-7	2928-2932	care	abstract[147]	giv[147]	_	_
20-8	2933-2935	if	_	_	_	_
20-9	2936-2940	they	person	giv	_	_
20-10	2941-2951	experience	_	_	_	_
20-11	2952-2961	shortness	abstract[149]	new[149]	_	_
20-12	2962-2964	of	abstract[149]	new[149]	_	_
20-13	2965-2971	breath	abstract[149]|abstract	new[149]|new	_	_
20-14	2972-2974	or	abstract[149]	new[149]	_	_
20-15	2975-2985	difficulty	abstract[149]|abstract|abstract[152]	new[149]|giv|giv[152]	coref	21-18[161_152]
20-16	2986-2995	breathing	abstract[149]|abstract[152]	new[149]|giv[152]	_	_
20-17	2996-2997	,	_	_	_	_
20-18	2998-3000	or	_	_	_	_
20-19	3001-3003	if	_	_	_	_
20-20	3004-3005	a	abstract[153]|abstract[154]	giv[153]|new[154]	coref|coref	20-24[155_153]|21-24[163_154]
20-21	3006-3011	fever	abstract[153]|abstract[154]	giv[153]|new[154]	_	_
20-22	3012-3013	,	abstract[154]	new[154]	_	_
20-23	3014-3017	and	abstract[154]	new[154]	_	_
20-24	3018-3028	especially	abstract[154]|abstract[155]	new[154]|giv[155]	coref	21-24[0_155]
20-25	3029-3033	high	abstract[154]|abstract[155]	new[154]|giv[155]	_	_
20-26	3034-3039	fever	abstract[154]|abstract[155]	new[154]|giv[155]	_	_
20-27	3040-3041	,	_	_	_	_
20-28	3042-3051	continues	_	_	_	_
20-29	3052-3056	more	time[156]	giv[156]	_	_
20-30	3057-3061	than	time[156]	giv[156]	_	_
20-31	3062-3067	three	time[156]	giv[156]	_	_
20-32	3068-3072	days	time[156]	giv[156]	_	_
20-33	3073-3074	.	_	_	_	_

#Text=For parents with a young child who is ill , seek medical care if a child has fast or labored breathing , continuing fever or convulsions ( seizures ) .
21-1	3075-3078	For	_	_	_	_
21-2	3079-3086	parents	person[157]	new[157]	_	_
21-3	3087-3091	with	person[157]	new[157]	_	_
21-4	3092-3093	a	person[157]|person[158]	new[157]|new[158]	coref	21-15[160_158]
21-5	3094-3099	young	person[157]|person[158]	new[157]|new[158]	_	_
21-6	3100-3105	child	person[157]|person[158]	new[157]|new[158]	_	_
21-7	3106-3109	who	_	_	_	_
21-8	3110-3112	is	_	_	_	_
21-9	3113-3116	ill	_	_	_	_
21-10	3117-3118	,	_	_	_	_
21-11	3119-3123	seek	_	_	_	_
21-12	3124-3131	medical	abstract[159]	giv[159]	_	_
21-13	3132-3136	care	abstract[159]	giv[159]	_	_
21-14	3137-3139	if	_	_	_	_
21-15	3140-3141	a	person[160]	giv[160]	_	_
21-16	3142-3147	child	person[160]	giv[160]	_	_
21-17	3148-3151	has	_	_	_	_
21-18	3152-3156	fast	abstract[161]	giv[161]	_	_
21-19	3157-3159	or	abstract[161]	giv[161]	_	_
21-20	3160-3167	labored	abstract[161]	giv[161]	_	_
21-21	3168-3177	breathing	abstract[161]	giv[161]	_	_
21-22	3178-3179	,	_	_	_	_
21-23	3180-3190	continuing	_	_	_	_
21-24	3191-3196	fever	abstract|abstract[163]	giv|giv[163]	_	_
21-25	3197-3199	or	abstract[163]	giv[163]	_	_
21-26	3200-3211	convulsions	abstract[163]|abstract	giv[163]|new	appos	21-28
21-27	3212-3213	(	_	_	_	_
21-28	3214-3222	seizures	abstract	giv	_	_
21-29	3223-3224	)	_	_	_	_
21-30	3225-3226	.	_	_	_	_
